NASDAQ: XRTX
Xortx Therapeutics Inc Stock Ownership - Who owns Xortx Therapeutics?

Insider buying vs selling

Have Xortx Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when XRTX insiders and whales buy or sell their stock.

XRTX Shareholders

What type of owners hold Xortx Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Citade0.00%23$53.59Institution
Citadel Advisors LLC0.00%23$53.59Institution
Stonex0.00%16$37.28Institution
Stonex Group Inc0.00%16$37.28Institution
Royal Bank Of Canada 10.00%1$2.33Institution
Roycan0.00%1$2.33Institution
Canada0.00%0$0.00Institution
Td Waterhouse Canada Inc0.00%0$0.00Institution
Clears0.00%0$0.00Institution
Clearstead Advisors LLC0.00%0$0.00Institution

1 of 2

XRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XRTX0.00%0.00%
BRTX0.00%100.00%Net Buying
ELAB0.00%100.00%
CVKD0.00%28.17%Net SellingNet Selling
TCRT0.00%100.00%Net BuyingNet Buying

Xortx Therapeutics Stock Ownership FAQ

Who owns Xortx Therapeutics?

Xortx Therapeutics (NASDAQ: XRTX) is owned by 0.00% institutional shareholders, 0.00% Xortx Therapeutics insiders, and 100.00% retail investors. Citade is the largest individual Xortx Therapeutics shareholder, owning 23.00 shares representing 0.00% of the company. Citade's Xortx Therapeutics shares are currently valued at $47.61.

If you're new to stock investing, here's how to buy Xortx Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.